Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Carcinoma of peritoneum

Known as: peritoneal carcinoma 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
PURPOSE The vascular disrupting agent fosbretabulin tromethamine selectively targets pre-existing tumor vasculature, which causes… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2012
Highly Cited
2012
OBJECTIVE The recent EORTC-NCIC randomized trial comparing primary debulking surgery (PDS) to neoadjuvant chemotherapy (NACT) in… Expand
  • figure 1
  • table 1
  • figure 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Inherited loss-of-function mutations in BRCA1 and BRCA2 and other tumor suppressor genes predispose to ovarian carcinomas, but… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2010
2010
PURPOSE Ixabepilone (BMS-247550) is a microtubule-stabilizing epothilone B analog with activity in taxane-resistant metastatic… Expand
  • figure 1
  • table 1
  • table 3
  • table 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
OBJECTIVE To determine the impact on progression-free survival (PFS) and overall survival (OS) of a programmatic change in… Expand
Is this relevant?
2006
2006
The outcome of screening and prophylactic surgery in 269 women at high risk of hereditary ovarian cancer is reported. Screening… Expand
  • table 1
  • table 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
OBJECTIVES Docetaxel is an inhibitor of microtubule depolymerization and has demonstrated activity in paclitaxel-resistant breast… Expand
Is this relevant?
2003
2003
OBJECTIVE Preclinical models in an ovarian cancer cell line (A2780) demonstrate synergistic activity with the combination of… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
OBJECTIVE Positive emission tomography (PET) provides a novel means of imaging malignancies. The following study was undertaken… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
PURPOSE The combination of paclitaxel and a platinum compound is the most active first-line regimen for advanced ovarian… Expand
Is this relevant?